Skip to main content
. Author manuscript; available in PMC: 2016 Dec 8.
Published in final edited form as: Nano Lett. 2016 Jun 14;16(7):3989–3994. doi: 10.1021/acs.nanolett.6b00320

Figure 4.

Figure 4

Aβ42 and tau-PS262 dynamics. (a) Aβ42 and tau-PS262 levels were monitored in the same SH-SY5Y-tau cell when no isoflurane was applied (control condition). (b) Aβ42 and tau-PS262 levels were monitored after the treatment of isoflurane in the SH-SY5Y-tau cell up to 16 h. (c, d) Dynamic Aβ42 and tau-PS262 levels in SH-SY5Y-tau cells, which were preconditioned with 0.5 μM γ-secretase inhibitor (c) or 3 μM phosphorylation kinase inhibitor K252a (d) prior to the isoflurane treatment.